Patent details

EP2021006 Title: USE OF FLIBANSERIN FOR THE TREATMENT OF POST-MENOPAUSAL SEXUAL DESIRE DISORDERS

Basic Information

Publication number:
EP2021006
PCT Application Number:
PCT/EP/2007/054380
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP077288330
PCT Publication Number:
WO/2007/128802
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
USE OF FLIBANSERIN FOR THE TREATMENT OF POST-MENOPAUSAL SEXUAL DESIRE DISORDERS
French Title of Invention:
UTILISATION DE FLIBANSERINE POUR LE TRAITEMENT DES TROUBLES DE LA LIBIDO POST-MENOPAUSIQUES
German Title of Invention:
VERWENDUNG VON FLIBANSERIN ZUR BEHANDLUNG VON POSTMENOPAUSALEN STÖRUNGEN DES SEXUELLEN VERLANGENS
SPC Number:

Dates

Filing date:
07/05/2007
Grant date:
12/08/2015
EP Publication Date:
12/08/2015
PCT Publication Date:
15/11/2007
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
11/02/2009
EP B1 Publication Date:
12/08/2015
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
07/05/2016
Expiration date:
07/05/2027
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
07/05/2007
 
 

Name:
Sprout Pharmaceuticals Inc.
Address:
4208 Six Forks Road, Suite 1010, Raleigh, NC 27609, United States (US)

Inventor

1

Name:
POLLENTIER Stephane
Address:
Netherlands (NL)

2

Name:
PYKE Robert
Address:
United States (US)

Priority

1

Priority Number:
746817 P
Priority Date:
09/05/2006
Priority Country:
United States (US)

2

Priority Number:
830987 P
Priority Date:
14/07/2006
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/496;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages